Atossa Therapeutics, Inc. (ATOS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 36.67M | 45.62M | 55.68M | 62.52M | 68.74M | 74.46M | 77.11M | 81.72M | 87.06M | 92.22M | 97.65M | 106M |
| Cash & Short-Term Investments | 31.72M | 41.3M | 51.84M | 57.86M | 65.12M | 71.08M | 74.77M | 79.53M | 84.07M | 88.46M | 94.03M | 99.5M |
| Cash Only | 31.72M | 41.3M | 51.84M | 57.86M | 65.12M | 71.08M | 74.77M | 79.53M | 84.07M | 88.46M | 94.03M | 99.5M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 737K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 3.48M | 0 | 0 | 0 | 1.09M | 1.37M | 1.49M | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | 28.06K | 26.02K | 9.77K | - | - |
| Other Current Assets | 4.95M | 4.32M | 3.83M | 676K | 378K | 229K | 258K | 518K | 508K | 977K | 117K | 7K |
| Total Non-Current Assets | 1.27M | 1.99M | 2.33M | 2M | 2M | 1.99M | 2.37M | 4.14M | 4.03M | 4.03M | 4.05M | 2.35M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M |
| Other Non-Current Assets | 1.27M | 1.99M | 2.33M | 2M | 2M | 1.99M | 2.37M | 2.43M | 2.32M | 2.32M | 2.34M | 642K |
| Total Assets | 37.94M | 47.61M | 58.01M | 64.52M | 70.75M | 76.44M | 79.48M | 85.86M | 91.09M | 96.25M | 101.69M | 108.36M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x | - | - |
| Asset Growth % | -46.37% | -37.72% | -27.01% | -24.86% | -22.33% | -20.58% | -21.85% | -20.76% | -21.61% | -22.08% | -19.75% | -19.17% |
| Total Current Liabilities | 7.46M | 8.26M | 8.22M | 6.82M | 5.42M | 4.97M | 5.8M | 5.7M | 5.33M | 5.24M | 3.44M | 3.48M |
| Accounts Payable | 2.57M | 4.29M | 3.54M | 2.01M | 1.17M | 679K | 1.56M | 1.06M | 1.23M | 806K | 718K | 1.17M |
| Days Payables Outstanding | 77.2K | - | 63.78K | - | - | 25.76K | 30.1K | 26K | 18.53K | 5.01K | 29.01K | 39.71K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.89M | 3.96M | 4.69M | 1.56M | 2.11M | 3.04M | 2.42M | 1.79M | 3.44M | 1.8M | 1.28M | 849K |
| Current Ratio | 4.92x | 5.53x | 6.77x | 9.17x | 12.67x | 14.99x | 13.30x | 14.35x | 16.34x | 17.61x | 28.35x | 30.48x |
| Quick Ratio | 4.92x | 5.53x | 6.77x | 8.66x | 12.67x | 14.99x | 13.30x | 14.15x | 16.08x | 17.33x | 28.35x | 30.48x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.46M | 8.26M | 8.22M | 6.82M | 5.42M | 4.97M | 5.8M | 5.7M | 5.33M | 5.24M | 3.44M | 3.48M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -31.72M | -41.3M | -51.84M | -57.86M | -65.12M | -71.08M | -74.77M | -79.53M | -84.07M | -88.46M | -94.03M | -99.5M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -9.46x | - | - |
| Total Equity | 30.49M | 39.35M | 49.79M | 57.7M | 65.32M | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M | 98.25M | 104.88M |
| Equity Growth % | -53.33% | -44.94% | -32.43% | -28.03% | -23.83% | -21.47% | -25.01% | -23.57% | -24.28% | -22.84% | -20.67% | -19.48% |
| Book Value per Share | 3.54 | 4.57 | 5.78 | 6.70 | 7.59 | 8.47 | 8.79 | 9.56 | 10.26 | 10.90 | 11.72 | 12.42 |
| Total Shareholders' Equity | 30.49M | 39.35M | 49.79M | 57.7M | 65.32M | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M | 98.25M | 104.88M |
| Common Stock | 1.55M | 1.55M | 23.49M | 23.49M | 23.49M | 23.49M | 22.88M | 22.87M | 22.83M | 22.79M | 22.79M | 22.79M |
| Retained Earnings | -256.15M | -246.56M | -235.63M | -226.93M | -218.51M | -211.79M | -205.44M | -198.22M | -192.17M | -186.29M | -178.53M | -172.31M |
| Treasury Stock | 0 | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M | -152K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |